Medivir AB (publ) (LON:0GP7)
London
· Delayed Price · Currency is GBP · Price in SEK 1.760
-0.016 (-0.90%)
At close: Jun 4, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Pharmaceutical | 7.63M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Growth | 73.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Royalties | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Royalties Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Out-licensing and Collaboration Agreements | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Out-licensing and Collaboration Agreements Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
United States | 3.58M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe, Other | 3.31M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe, Other Growth | -7.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of the World | 367.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of the World Growth | -16.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sweden | 192.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sweden Growth | -13.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nordic Region, Other | 186.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nordic Region, Other Growth | -0.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|